Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Equity (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Return on Equity for 14 consecutive years, with 0.16% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 6.0% to 0.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.16% through Dec 2025, down 6.0% year-over-year, with the annual reading at 0.15% for FY2025, 9.0% down from the prior year.
  • Return on Equity hit 0.16% in Q4 2025 for Corcept Therapeutics, down from 0.17% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.29% in Q1 2022 to a low of 0.16% in Q4 2025.
  • Historically, Return on Equity has averaged 0.21% across 5 years, with a median of 0.21% in 2022.
  • Biggest five-year swings in Return on Equity: rose 9bps in 2022 and later dropped -10bps in 2023.
  • Year by year, Return on Equity stood at 0.25% in 2021, then dropped by -15bps to 0.21% in 2022, then increased by 5bps to 0.22% in 2023, then fell by -2bps to 0.21% in 2024, then fell by -27bps to 0.16% in 2025.
  • Business Quant data shows Return on Equity for CORT at 0.16% in Q4 2025, 0.17% in Q3 2025, and 0.2% in Q2 2025.